Quellen
[1] Bangalore, L. (2025, 21. Januar). Cannabinoids offer new hope for safe and effective pain relief. Yale News. Abgerufen am [aktuelles Datum], von
https://news.yale.edu/2025/01/21/cannabinoids-offer-new-hope-safe-and-effective-pain-relief
[2] Ghovanloo, M.-R., Tyagi, S., Zhao, P., & Waxman, S. G. (2025). Nav1.8, an analgesic target for nonpsychotomimetic phytocannabinoids. Proceedings of the National Academy of Sciences of the United States of America, 122(4), e2416886122.
[3] Bradford, A. C., & Bradford, W. D. (2016). Medical marijuana laws reduce prescription medication use in Medicare Part D. Health Affairs, 35(7), 1230–1236.
[4] Ware, M. A., Wang, T., Shapiro, S., Collet, J. P. (2010). Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. Canadian Medical Association Journal, 182(14), E694–E701.
https://doi.org/10.1503/cmaj.091414
[5] Collin, C., Davies, P., Mutiboko, I. K., Ratcliffe, S. (2007). Randomized, double‑blind, placebo‑controlled trial of cannabis‑based medicine in spasticity caused by multiple sclerosis. Eur J Neurol, 14(3), 290–296.